United Therapeutics sues Sandoz over hypertension drug

(Reuters) - United Therapeutics Corp said it filed a lawsuit against Novartis AG's generic unit Sandoz, alleging infringement of the biotechnology company's patent on its pulmonary hypertension drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.